NCRM has been primarily involved in research on Corneal Limbal stem cells, Corneal Eendothelial Precursors , Hepatic Progenitors, Chondrocytes and Hematopoetic Stem Cells

We provide autologous bone marrow stem cell processing services which is considered as an experimental therapy for various illnesses as per ICMR Guidelines
Our services are provided to hospitals when such applications are approved by the IC-SCRT(Institutional Committee for Stem cell Research and Therapy) and IEC(Institutional Ethics Committee) of those hospitals/Institutes

Peer Reviewed publications have reported the safety and efficacy of Autologous Bone Marrow Stem Cells for conditions such as:

1. Peripheral Vascular Diseases /Critical limb ischemia

2. End Stage Heart Failure ( Ischemic heart diseases / cardiomyopathy)

3. Spinal cord injury

4. Cirrhosis of Liver